drugset / Trial / NCT03192488

Effect of an H1 Receptor Antagonist on Exercise Performance in Hypoxia

NCT03192488

Phase 4 Completed 13 enrolled Indiana University
RandomizedCrossoverDouble-blindBasic science

Summary

This study seeks to determine whether a simple, single intervention of Cetirizine / Zyrtec® use can improve exercise performance of active individuals when acutely exposed to altitude. For this project, healthy subjects will perform steady state and progressive work rate exercise, endurance performance time trials, and repeated sprint performance time trials in the laboratory at a simulated altitude of 3000m (9900ft) after dosing with 10 mg of Cetirizine or a placebo in a repeated measures design.

Timeline

Start
2017-08-31
Primary completion
2018-06-06
Completion
2018-06-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetirizine Other / unclassified 10 mg Oral

Indications